• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

durvalumab - Articles and news items

Global urological cancers market to double by 2022, says GBI Research

Industry news / 30 June 2016 / Victoria White, Digital Content Producer

The urological cancers market will increase from $17.9 billion in 2015 to $35.9 billion by 2022, according to business intelligence provider GBI Research…

 

Webinar: Understanding ISO Standards: ISO 14644-2:2015 Cleanroom MonitoringFIND OUT MORE
+ +